Citizen Petition from PJ O'Brien & Associates
FDA-2025-P-0335-0001Other
Comments
2
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
+100%
+100% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from PJ O'Brien & Associates
- Posted
- Jan 30, 2025
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
+100%
Net support
Support2
Aggregates include form-letter campaigns. Excluding them, net support is +100% across organic comments.
Who commented
Breakdown by commenter type.
Advocacy
1
Other
1
Comments over time
Weekly arrivals, stacked by stance.
Posted Jan 30, 2025
May 4
Support2Oppose0Other0
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Advocacy
100%
0%
0%
Other
100%
0%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
- May 7, 2026Comment from AnonymousSupportOther
PJ O'Brien & Associates submits a technical memorandum supporting a citizen petition to stay and revoke the BLA for Comirnaty (Tozinameran). They argue that the presence of residual DNA during the manufacturing process creates "Non-Conforming Species" and "Structural Adulteration," making the product non-compliant with its licensed identity.
Read comment → - May 4, 2026Comment from David BeharSupportAdvocacy📎 AttachmentRead comment →